NCT01861808View on ClinicalTrials.gov

Prognostic Value of Biochemical Markers in Cerebrospinal Fluid for Functional Outcome of Spinal Cord Injured Patients

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 24, 2013

Primary Completion Date

September 1, 2016

Study Completion Date

August 31, 2017

Conditions
Spinal Cord Injuries
Interventions
OTHER

Lumbar puncture

The only intervention is the lumbar puncture on the patients to obtain a Cerebrospinal Fluid sample

Trial Locations (4)

40026

Montecatone Rehabilitation Institute SpA, Imola

40064

Centro Interdipartimentale Ricerca Industriale Università degli Studi, Ozzano Monferrato

40133

UOC Rianimazione CO e 118 Ospedale Maggiore AUSL, Bologna

UOSD Chirurgia Vertebrale di Urgenza e del Trauma Ospedale Maggiore AUSL, Bologna

All Listed Sponsors
lead

Azienda Usl di Bologna

OTHER_GOV

NCT01861808 - Prognostic Value of Biochemical Markers in Cerebrospinal Fluid for Functional Outcome of Spinal Cord Injured Patients | Biotech Hunter | Biotech Hunter